Biotechnology Stocks I Performance Guide: Apellis Pharmaceuticals, Inc. (APLS)
APLS has no dividends
Table and Chart of APLS Performance
See what a $1,000 investment in APLS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| APLS Returns | |
|---|---|
| Start Date | Dec-29-2017 |
| Start Price | $21.70 |
| End Date | Dec-01-2023 |
| End Price | $61.58 |
| # Prices | 73 |
| Min Date | Dec-31-2018 |
| Min Price | $13.19 |
| Max Date | Jun-30-2023 |
| Max Price | $91.10 |
| Total Return | 183.78% |
| Annualized Return | 18.70% |
| Current Value of $1,000 Purchase | $2,838 |
| Number Returns | 2,628 |
| Average Return | 82.24% |
| Number Profitable Returns | 2,166 |
| Percent Profitable Returns | 82.42% |
| Number Unprofitable Returns | 462 |
| Percent Unprofitable Returns | 17.58% |
| Profitable to Unprofitable Returns Ratio | 4.69 |
| APLS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $7,304,373,000 | Price to Sales | 26.77 |
| Earnings per Share | $-5.2300 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 31.39 |
| PRICE DATA | |
| 52 Week High | $94.75 |
| 52 Week Low | $19.83 |
| Analyst Target Price | $71.19 |
| 50-Day Moving Average | $46.16 |
| 200-Day Moving Average | $60.75 |
| FINANCIAL DATA | |
| Revenue per Share | $2.352 |
| Revenue | $272,877,000 |
| Profit Margin | -222.1% |
| Return on Equity | -2.246% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
APLS Compare Returns with S&P 500
APLS Trendline Chart